SBIR/STTR Research Award
Construction of bacteriophage nanoparticles for targeted delivery of nucleic acid therapeutics
Award amount
$289,826Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SynPhaGen, LLC
- Proposal award date
- 2015-09-10
- Contract end date
- 2016-09-09
- UEI
- Not reported
- Solicitation number
- PA14-307
- Topic code
- 100
Research abstract
DESCRIPTION provided by applicant
The research proposed in this application is for the development of a platform technology for the delivery of therapeutic genes to commensal bacteria associated with the human body The successful development of the technology will result in the creation of a vehicle for the delivery of genes to bacteria inhabiting specific areas of the body transforming the bacteria into localized andquot therapeutic factoriesandquot The research objectives include the targeted delivery of nucleic
acids encoding reporter genes therapeutic proteins or regulatory RNA to both Gram negative and Gram positive organisms Proof of concept studies will demonstrate the flexibility and utility of the platform and the delivery of therapeutic immunomodulatory genes in vivo using a mouse model The platform technology has the advantage of being adaptable stable and cost effective and has broad application to human health including treatment of chronic disease conditions immunotherapy and vaccine development
PUBLIC HEALTH RELEVANCE
The research proposed in this application is for the development of a platform technology for the delivery of therapeutic genes to commensal bacteria associated with the human body The successful development of the technology will result in the creation of a vehicle for the delivery of genes to bacteria inhabiting specific areas of the body transforming the bacteria into localized andquot therapeutic factoriesandquot The platform technology has the advantage of being adaptable stable and cost effective and has broad application to human health including treatment of chronic disease conditions immunotherapy and vaccine development
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing